ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
DrillDown2014
|
121 |
30K |
3 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
121
|
30K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric opens CHM CDH17 Phase 1/2 trial
|
|
DrillDown2014
|
14 |
3.0K |
8 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
14
|
3.0K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Resignation of CEO and Managing Director
|
|
DrillDown2014
|
61 |
20K |
3 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
61
|
20K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: CHM CDH17 Phase 1/2 clinical trial approved for initiation
|
|
DrillDown2014
|
17 |
5.4K |
11 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
17
|
5.4K
|
11
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
DrillDown2014
|
121 |
30K |
2 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
121
|
30K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
DrillDown2014
|
121 |
30K |
2 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
121
|
30K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
DrillDown2014
|
121 |
30K |
5 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
121
|
30K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
DrillDown2014
|
121 |
30K |
3 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
121
|
30K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
DrillDown2014
|
121 |
30K |
7 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
121
|
30K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Dr Rebecca McQualter appointed COO
|
|
DrillDown2014
|
14 |
5.3K |
6 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
14
|
5.3K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
DrillDown2014
|
6 |
1.9K |
4 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
6
|
1.9K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
DrillDown2014
|
428 |
150K |
5 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
428
|
150K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
DrillDown2014
|
428 |
150K |
1 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
428
|
150K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
DrillDown2014
|
428 |
150K |
12 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
428
|
150K
|
12
|
|
ASX - By Stock
|
SYR |
Re:
Media Reports
|
|
DrillDown2014
|
3.5K |
1.3M |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
3.5K
|
1.3M
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial
|
|
DrillDown2014
|
75 |
25K |
8 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
75
|
25K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
DrillDown2014
|
34 |
10K |
1 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
34
|
10K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
DrillDown2014
|
34 |
10K |
2 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
34
|
10K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: ADVENT-AML Phase 1B clinical trial open to enrolment
|
|
DrillDown2014
|
24 |
7.6K |
12 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
24
|
7.6K
|
12
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Investor Presentation
|
|
DrillDown2014
|
10 |
3.4K |
0 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
10
|
3.4K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Investor Presentation
|
|
DrillDown2014
|
10 |
3.4K |
2 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
10
|
3.4K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
CHM Bell Potter booking building
|
|
DrillDown2014
|
24 |
5.1K |
3 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
24
|
5.1K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: CHM Secures Further $1M Investment
|
|
DrillDown2014
|
15 |
5.9K |
2 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
15
|
5.9K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in CHM 0201 Vactosertib trial
|
|
DrillDown2014
|
16 |
7.9K |
1 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
16
|
7.9K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
DrillDown2014
|
75 |
22K |
7 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
75
|
22K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
DrillDown2014
|
428 |
150K |
7 |
30/12/23 |
30/12/23 |
ASX - By Stock
|
428
|
150K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric to present at Biotech Showcase at JPM week
|
|
DrillDown2014
|
19 |
7.2K |
20 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
19
|
7.2K
|
20
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric to present at Biotech Showcase at JPM week
|
|
DrillDown2014
|
19 |
7.2K |
15 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
19
|
7.2K
|
15
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
|
|
DrillDown2014
|
56 |
19K |
9 |
09/12/23 |
09/12/23 |
ASX - By Stock
|
56
|
19K
|
9
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Phase 1B ADVENT-AML trial to be presented at ASH meeting
|
|
DrillDown2014
|
7 |
3.0K |
9 |
09/12/23 |
09/12/23 |
ASX - By Stock
|
7
|
3.0K
|
9
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
DrillDown2014
|
75 |
22K |
7 |
09/12/23 |
09/12/23 |
ASX - By Stock
|
75
|
22K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Completion of Entitlement Offer
|
|
DrillDown2014
|
44 |
12K |
5 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
44
|
12K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Completion of Entitlement Offer
|
|
DrillDown2014
|
44 |
12K |
8 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
44
|
12K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Completion of Entitlement Offer
|
|
DrillDown2014
|
44 |
12K |
4 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
44
|
12K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
SPP
|
|
DrillDown2014
|
3 |
743 |
1 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
3
|
743
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Positive in vitro data for CHM 1301 CAR NK cells-supplement
|
|
DrillDown2014
|
7 |
3.2K |
7 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
7
|
3.2K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Positive in vitro data for CHM 1301 CAR NK cells
|
|
DrillDown2014
|
79 |
20K |
2 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
79
|
20K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Positive in vitro data for CHM 1301 CAR NK cells
|
|
DrillDown2014
|
79 |
20K |
2 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
79
|
20K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer closing date extended to 30 November 2023
|
|
DrillDown2014
|
29 |
9.5K |
3 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
29
|
9.5K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Presentation to Annual General Meeting
|
|
DrillDown2014
|
3 |
1.4K |
10 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
3
|
1.4K
|
10
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
DrillDown2014
|
75 |
22K |
6 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
75
|
22K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
DrillDown2014
|
75 |
22K |
7 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
75
|
22K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
DrillDown2014
|
75 |
22K |
4 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
75
|
22K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $10 million
|
|
DrillDown2014
|
99 |
31K |
1 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
99
|
31K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $10 million
|
|
DrillDown2014
|
99 |
31K |
8 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
99
|
31K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $10 million
|
|
DrillDown2014
|
99 |
31K |
2 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
99
|
31K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial
|
|
DrillDown2014
|
75 |
25K |
11 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
75
|
25K
|
11
|
|
ASX - By Stock
|
CHM |
Re:
Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial
|
|
DrillDown2014
|
75 |
25K |
24 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
75
|
25K
|
24
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Agreement with MD Anderson for Phase 1B CHM 0201 AML study
|
|
DrillDown2014
|
23 |
9.0K |
6 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
23
|
9.0K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Dosing completion in Phase 1A brain cancer clinical trial
|
|
DrillDown2014
|
34 |
10K |
0 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
34
|
10K
|
0
|
|